Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vaccine adverse event reporting

Executive Summary

CBER will hold a Sept. 27-29 workshop on "Harmonization of Reporting of Adverse Events Following Vaccination," FDA announces in Federal Register Aug. 12. The workshop will address systems used to process and monitor vaccine adverse event reports, requirements for surveillance databases, and standardized data- specific fields for worldwide dissemination of information. FDA said the workshop will assist CBER in preparing a guidance consistent with international programs. The workshop will be held at the Bethesda Holiday Inn, beginning at 8 a.m.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS023197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel